Bayer AG's total inventories for the quarter that ended in Mar. 2026 was lei62,849 Mil. Bayer AG's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was lei64,104 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Bayer AG's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was lei-302.20.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Bayer AG's Days Inventory for the
three
months ended in Mar. 2026 was 213.72.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bayer AG's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.43.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bayer AG's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.91.
Bayer AG (BSE:BAYN) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Bayer AG's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bayer AG's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Bayer AG Total Inventories Related Terms
Bayer AG Total Inventories Historical Data
* Premium members only.
The historical data trend for Bayer AG's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
What does a Total Inventories of lei62,849 Mil mean?
Bayer AG (BSE:BAYN) has a Total Inventories of lei62,849 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Bayer AG and its competitors.
Is Bayer AG's Total Inventories too high?
Bayer AG's current Total Inventories is lei62,849 Mil. Overall, Bayer AG has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's Total Inventories compare to LLY and JNJ?
Bayer AG's Total Inventories of lei62,849 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Bayer AG and its competitors. Bayer AG's current Total Inventories is lei62,849 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (BSE:BAYN) is currently considered Significantly Overvalued. The stock's GF Value™ is lei139.16, compared to a current price of lei209.00 — trading 50.2% above its estimated fair value. The current Total Inventories is lei62,849 Mil. Bayer AG's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Bayer AG (BSE:BAYN), the current Total Inventories is lei62,849 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bayer AG (BSE:BAYN) Overvalued in 2026?
Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued.
The current stock price of lei209.00 is trading 50.2% above its estimated GF Value™ of lei139.16.
GuruFocus considers Bayer AG to be Significantly Overvalued.
Key valuation signals for BSE:BAYN:
Total Inventories: lei62,849 Mil
GF Value™: lei139.16 vs. price of lei209.00 (50.2% above fair value)
No single metric tells the full story. See the BSE:BAYN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
76GF Score
Get the complete analysis for BSE:BAYN
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSE:BAYN has been successfully added to your 
